Condition
Lymphoma Patients
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT04673266Phase 2CompletedPrimary
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
NCT06920095Not ApplicableEnrolling By InvitationPrimary
Progressive Muscle Relaxation Exercises on Sleep, Fatigue, Pain in Lymphoma Patients
Showing all 2 trials